Overview
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 8
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Aug 30, 2025 | PainTEQ: Funding Raised To Advance Minimally Invasive SI Joint Solutions | PainTEQ, a leading developer of minimally invasive treatments for sacroiliac (SI) joint dysfunction, announced a majority growth recapitalization co-led by Signet Healthcare Partners and Windham Capital Partners, two U.S.-based healthcare i... |
| Aug 27, 2025 | PainTEQ Announces Majority Growth Recapitalization | Shanth Thiyagalingam, Chief Executive Officer, PainTEQ PainTEQ, a Tampa, FL-based company which specializes in minimally invasive solutions for sacroiliac (SI) joint dysfunction, received a majority growth recapitalization co-led by Signet ... |
| Jul 10, 2023 | PainTEQ Lands $35M Debt Financing | TAMPA, FL, PainTEQ, a provider of minimally invasive posterior sacroiliac (SI) joint fusion procedures, announced a $35 million debt financing round. >> Click here for more funding data on PainTEQ >> To export PainTEQ fundin... |
| Jun 2, 2023 | 20 Tips To Optimize Your Team's Performance Level Without Burnout | getty |
| Nov 4, 2020 | PainTEQ announces national headquarter office in Tampa | |
| Aug 17, 2020 | Health tech companies claim their largest share of the Inc. 5,000 to date with 123 entries | |
| PainTEQ | “Minimally Invasive No Metal Implanted Faster Recovery Time Than Traditional Fusion Posterior Approach Away From Nerves and Large Blood Vessels” |
Reviews 0
FAQ about PainTEQ
When was PainTEQ founded?
PainTEQ was founded in 2013.
What has the press written about PainTEQ?
Parsers VC has collected 8 articles mentioning PainTEQ, among them “PainTEQ: Funding Raised To Advance Minimally Invasive SI Joint Solutions” (Aug 30, 2025) and “PainTEQ Announces Majority Growth Recapitalization” (Aug 27, 2025).
Is PainTEQ still active?
Yes, PainTEQ is active; its latest activity on Parsers VC dates from Jul 10, 2026.